Literature DB >> 35410103

Correction: Anastopoulos et al. Multi-Drug Featurization and Deep Learning Improve Patient-Specific Predictions of Adverse Events. Int. J. Environ. Res. Public Health 2021, 18, 2600.

Ioannis N Anastopoulos1,2, Chloe K Herczeg2, Kasey N Davis2, Atray C Dixit2.   

Abstract

In the original publication [...].

Entities:  

Year:  2022        PMID: 35410103      PMCID: PMC8998796          DOI: 10.3390/ijerph19074216

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


In the original publication [1], there was a mistake in the colors associated with Figure 4A. The colors of the boxplots were incorrect.
Figure 4

Performance comparisons on the FAERS dataset. (A) Predictive utility of various features and model architectures for predicting adverse events in the FAERS dataset. X-axis labels correspond to adverse event categories for a particular case. Y-axis is the AUC at predicting each of the labels. Colors correspond to various feature subsets tested. Error bars correspond to 95% confidence interval derived from bootstrapping on 5-fold cross-validation (each fold contains 28,682 records). (B) Power analysis demonstrating improvement in performance as a function of the number of patient records examined. Blue corresponds to hospitalization model performance and orange corresponds to performance of model predicting death. X-axis is log10 (number of records) Y-axis is AUC. Shaded error region corresponds to 95% confidence interval derived from bootstrapping on 5-fold cross-validation in a subsampled dataset corresponding to the X-axis location. (C) Plot demonstrating relationship between model error across all outcomes and age, (D) average molecular weight of drugs patient is taking, and (E) patient sex.

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.
  1 in total

1.  Multi-Drug Featurization and Deep Learning Improve Patient-Specific Predictions of Adverse Events.

Authors:  Ioannis N Anastopoulos; Chloe K Herczeg; Kasey N Davis; Atray C Dixit
Journal:  Int J Environ Res Public Health       Date:  2021-03-05       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.